Several guidance documents have been published by the Medicines and Healthcare products Regulatory Agency (MHRA) in December 2020 and subsequently, including guidelines on the UK Responsible Person (UKRP) and UK… Read More
Medtech Insight has just recently published an article on the updated guidance from for the post-Brexit era. The Medicines and Healthcare products Regulatory Agency (MHRA) issued a guidance update on… Read More
On September 1, 2020, the UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued a new guidance how medical devices will be regulated post-Brexit as of January 1, 2021.… Read More
31 January 2020 was a somewhat significant day as the UK formally left the EU at a strategic point in the implementation of the Medical Devices and IVD Regulations (EU)… Read More
What many may already have expected has now been confirmed. UK Prime Minister Boris Johnson has been forced by the House of Commons to request another delay of Brexit date… Read More
The UK has updated its guidance on the UK Responsible Person. The document is applicable should the UK leave the EU without a deal and includes important details about the… Read More
Although there is less than 3 months to go until the Brexit date, conditions have not yet been agreed upon and it is likely that a no-deal will be reached. … Read More
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) publishes guidance about registration fees and requirements for a No-Deal Brexit These include, among others, legislative information, information about CE Marking… Read More
You may already have asked yourself how Brexit may affect your business. This is a very complex question as it strongly depends on the role of your company, your overall… Read More
On June 23, 2016, the United Kingdom (UK) voted for the UK to leave the EU, which is commonly referred to as Brexit. Since then, there has been no clear… Read More
